BURLINGTON, Mass., May 4, 2026 /PRNewswire/ -- SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual ...
BURLINGTON, Mass., April 21, 2026 /PRNewswire/ -- SQ Innovation, developer of Lasix ONYU, today announced a collaboration with Walmart Specialty Pharmacy to expand nationwide access to this recently ...
Treating people for heart failure with the loop diuretic medication torsemide did not reduce death rates more than the most common diuretic medication furosemide. Researchers say health care ...
The choice of loop diuretic for decongestion in patients hospitalized with heart failure (HF) may make little difference to survival or readmission risk over the next year, at least when deciding ...
A clinical trial funded by the National Institute of Health (NIH) revealed there is no significant difference in the effectiveness of furosemide and torsemide, two heart failure drugs, when it comes ...
After hospital discharge for heart failure, people treated with either loop diuretic medication furosemide or torsemide had similar death and hospitalization rates, according to late-breaking science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results